Morningstar

Pulse Biosciences Inc PLSE

Morningstar Rating

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results

Business Wire Aug 12, 2024 8:05pm
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors

Business Wire Aug 12, 2024 8:01pm
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System

Business Wire Aug 8, 2024 12:00pm
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Business Wire Aug 1, 2024 8:05pm
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Pulse Biosciences, Inc. (NASDAQ: PLSE)

PR Newswire Aug 1, 2024 3:44pm
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024

Business Wire Jul 29, 2024 8:05pm
Pulse Biosciences Hit 2-Year High on FDA Status for Surgery System

Global News Select Jul 8, 2024 3:19pm
Pulse Biosciences Gets FDA's Breakthrough Status for Surgery System

Global News Select Jul 8, 2024 12:49pm
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation

Business Wire Jul 8, 2024 12:00pm
Pulse Biosciences Up 16% on Product Updates, Potential Stock Purchases by Duggan

Global News Select Nov 27, 2023 8:36pm
Pulse Biosciences Shares Climb On Application for Percutaneous Electrode Review

Global News Select Nov 21, 2023 5:14pm

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.